Abingdon Health (LON:ABDX) Releases Quarterly Earnings Results

Abingdon Health (LON:ABDX) announced its quarterly earnings data on Monday. The company reported GBX (0.53) (($0.01)) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Abingdon Health had a negative return on equity of 62.56% and a negative net margin of 20.72%.

Abingdon Health Stock Performance

Shares of ABDX opened at GBX 6.38 ($0.08) on Tuesday. The company has a debt-to-equity ratio of 46.64, a current ratio of 1.95 and a quick ratio of 1.96. The firm has a 50-day moving average of GBX 7.47 and a 200-day moving average of GBX 7.97. The company has a market cap of £12.35 million, a PE ratio of -15.51 and a beta of 0.13. Abingdon Health has a one year low of GBX 6 ($0.08) and a one year high of GBX 11.75 ($0.15).

Abingdon Health Company Profile

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval.